Table 2 Activity of products before and after the freeze-drying process (\(\stackrel{-}{X}\)+S; n = 8)
From: Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25
Cell line | SK-BR-3 | BT-474 |
|---|---|---|
IC50 before freeze-drying (ng/mL) | 11.29 ± 1.76 | 49.66 ± 6.00 |
IC50 after freeze-drying (ng/mL) | 12.79 ± 0.86 | 56.24 ± 7.04 |